ReviewFrontiers in pharmacology2022

Neoplasm Risk in Patients With Rheumatoid Arthritis Treated With Fostamatinib: A Systematic Review and Meta-analysis.

Yuehong Chen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.